180
Participants
Start Date
June 1, 2022
Primary Completion Date
October 1, 2025
Study Completion Date
April 1, 2026
TCOC treatment
The TCOC protocol is a chronic care, family-based and multidisciplinary childhood obesity treatment program involving behavior-changing techniques, based on current guidelines for best-practice and authoritative recommendations involving a multidisciplinary tertiary team of health care professionals.
Semaglutide 3 mg/ml
Participants will be instructed to initiate at 0.24 mg SC once weekly for 4 weeks, and in 4 week intervals, increase the dose until a dose of 2.4 mg is reached. In case of prolonged side effects the dose may be adjusted to lower than 2.4mg/week.
Placebo (Semaglutide 3 mg/ml)
Participants will be instructed to initiate at 0.24 mg SC once weekly for 4 weeks, and in 4 week intervals, increase the dose until a dose of 2.4 mg is reached. In case of prolonged side effects the dose may be adjusted to lower than 2.4mg/week.
RECRUITING
University of Copenhagen, Department of Biomedical Sciences, Copenhagen
NOT_YET_RECRUITING
Holbæk University Hospital, Holbæk
University of Leeds
OTHER
Karolinska Institutet
OTHER
Holbaek Sygehus
OTHER
Rigshospitalet, Denmark
OTHER
Signe Torekov
OTHER